Aortic Valve Stenosis
Conditions
Interventions
remimazolam used
propofol used
Sponsors
Nara Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients undergoing TAVI under general anesthesia
Exclusion criteria
Exclusion criteria: Patients who cannot speak daily in Japanese Patients who do not understand the explanation of the research content Patients with atrial fibrillation upon entering the operating room Patients with contraindications to using Remimazolam Patients contraindicated for propofol use Patients with acute mental illness Patients who have been offered to withdraw their consent after registration Patients who died during the operation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of hypotensive time from the start of anesthesia induction to the start of surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Time integral value of blood pressure decrease period at anesthesia induction time Presence or absence of hypertension at the time of induction of anesthesia Rate of change in cardiac output and peripheral vascular resistance during anesthesia induction time Amount of pressor agent used during anesthesia induction time Presence or absence of delirium in the intensive care unit after surgery Length of stay in the intensive care unit after surgery Death 30 days after surgery | — |
Countries
Japan
Contacts
Public ContactTaichi Kotani
Nara Medical University Anesthesiology
Outcome results
None listed